---
title: "港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案。 — post author — DecisionGateway"
description: "statement by post author, recorded 2026-11-11 — verbatim quote and source citation."
canonical_url: "https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8"
meta:
  "og:description": "statement by post author, recorded 2026-11-11 — verbatim quote and source citation."
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案。 — post author — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

statementSaid on 2026-11-11

# **港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案。**

A statement by post author, said on 2026-11-11. Statements are as reported by the cited publishers — not verified by DecisionGateway.

> *港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案*

rthk\_new\_cPublished 2026-11-11 [ Read source](https://t.me/rthk_new_c/401274)

## **Discussion**

## **Related claims**

[**港怡醫院和香港中文大學醫院正在以組織碎化技術進行胰臟癌臨床試驗。**post author · statement](https://dgw.tmarket.io/claims/01a1e96c-97ee-7e95-a08b-78d7b30f2e7c) [**中大醫院自今年6月3日開始，至今已成功完成6宗。**post author · statement](https://dgw.tmarket.io/claims/01a1e96c-9814-71ed-b61a-3fb238ca7444) [**Hong Kong has launched Asia's first kidney cancer clinical trial.**headline · statement](https://dgw.tmarket.io/claims/01a1ecba-5319-740a-b41b-f0f32d29c80b) [**過去兩年在香港已順利治療超過400名病人。**李嘉誠基金會 · statement](https://dgw.tmarket.io/claims/01a1e96c-97de-758e-b3a7-d531367011f8) [**此舉令香港成為亞洲首個推行組織碎化技術（Histotripsy）腎臟癌臨床試驗的城市。**李嘉誠基金會 · statement](https://dgw.tmarket.io/claims/01a1e96c-97d2-7460-b264-233588f7debe) [**Three pipelines are currently at the preclinical PCC stage and are progressing as planned.**昂利康 · statement](https://dgw.tmarket.io/claims/01a1e5e4-633e-79a8-af50-0f103ce4bd57)

[All claims](https://dgw.tmarket.io/claims)

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts — every claim cited to its public source. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8#webpage","@type":"WebPage","description":"statement by post author, recorded 2026-11-11 — verbatim quote and source citation.","name":"港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案。 — post author — DecisionGateway","url":"https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8","breadcrumb":{"@id":"https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Claims","item":"https://dgw.tmarket.io/claims","position":2},{"@type":"ListItem","name":"港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案。","position":3}]},{"@id":"https://dgw.tmarket.io/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8#/schema/quotation/1","@type":"Quotation","dateCreated":"2026-11-11","isBasedOn":"https://t.me/rthk_new_c/401274","text":"港怡自今年3月31日開始，已成功完成20宗胰臟腫瘤個案","url":"/claims/01a1e96c-9802-7563-9c4b-0a2374795ec8"}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.
